Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
80.2 CHF | -0.99% | -0.99% | -4.52% |
Apr. 04 | Global markets live: Novo Nordisk, Ocado, Walt Disney, Apple, Tesla... | |
Apr. 04 | Medartis Issues CFH116 Million Convertible Bonds | MT |
Sales 2024 * | 244M 265M | Sales 2025 * | 287M 312M | Capitalization | 1.09B 1.18B |
---|---|---|---|---|---|
Net income 2024 * | 8M 8.68M | Net income 2025 * | 14M 15.19M | EV / Sales 2024 * | 4.55 x |
Net Debt 2024 * | 22.74M 24.68M | Net Debt 2025 * | 18.44M 20.01M | EV / Sales 2025 * | 3.85 x |
P/E ratio 2024 * |
114
x | P/E ratio 2025 * |
68.3
x | Employees | 812 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 34.44% |
Latest transcript on Medartis Holding AG
1 day | -0.99% | ||
1 week | -0.99% | ||
Current month | -10.29% | ||
1 month | -10.29% | ||
3 months | +9.86% | ||
6 months | +13.12% | ||
Current year | -4.52% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 19-08-31 | |
Dirk W. Kirsten
DFI | Director of Finance/CFO | 56 | 21-02-28 |
Chief Operating Officer | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
H. C. Straumann
FOU | Founder | 61 | 97-11-02 |
Damien Tappy
BRD | Director/Board Member | 55 | 17-12-31 |
Marco Gadola
CHM | Chairman | 61 | 20-04-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - | |
0.00% | 34 M€ | +1.51% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 80.2 | -0.99% | 4,622 |
24-04-29 | 81 | -0.74% | 3,580 |
24-04-26 | 81.6 | +1.87% | 2,848 |
24-04-25 | 80.1 | -0.37% | 361 |
24-04-24 | 80.4 | -0.62% | 339 |
Delayed Quote Swiss Exchange, April 30, 2024 at 11:31 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.52% | 1.19B | |
+12.37% | 128B | |
-9.23% | 10.69B | |
+2.17% | 8.93B | |
+18.79% | 7.32B | |
+20.77% | 4.82B | |
+6.97% | 3.4B | |
-1.41% | 3.03B | |
-5.07% | 2.23B | |
-4.22% | 2.13B |
- Stock Market
- Equities
- MED Stock